Lyme disease vaccine candidate granted Fast Track designation

In a follow-up on the progress of the Lyme disease vaccine candidate VLA15, French company, Valneva announced today that the U.S. Food and Drug Administration (FDA) has granted the vaccine Fast Track designation. Fast Track designation is granted by the FDA to products that are under development for serious conditions and have the potential to fulfill ["]

The post Lyme disease vaccine candidate granted Fast Track designation appeared first on Outbreak News Today.